These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6326210)

  • 1. [Relation between a circulating inhibitor of sodium transport and arterial hypertension].
    Wardener HE; MacGregor GA
    Rev Esp Cardiol; 1983; 36(6):463-8. PubMed ID: 6326210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Natraemia, natriuresis, inhibitors of sodium transport and high blood pressure].
    de Wardener H
    Nephrol Ther; 2007 Dec; 3(7):433-6. PubMed ID: 18047997
    [No Abstract]   [Full Text] [Related]  

  • 3. The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension.
    de Wardener HE; MacGregor GA
    Medicine (Baltimore); 1983 Sep; 62(5):310-26. PubMed ID: 6312247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems and pitfalls in the isolation of an endogenous Na+, K+-ATPase inhibitor.
    Mir MA; Morgan K; Lewis M; Spurlock G; Chappell S; Lewis M; Scanlon M
    Hypertension; 1987 Nov; 10(5 Pt 2):I57-60. PubMed ID: 2824367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual variability in membrane sodium transport during salt loading--evidence against the production of a Na+-K+-ATPase inhibitor in hypertension.
    Maling TJ; Siebers RW
    Prog Biochem Pharmacol; 1988; 23():91-100. PubMed ID: 2847194
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence that the hypothalamus may be a source of a circulating Na+-K+-ATPase inhibitor.
    Alaghband-Zadeh J; Fenton S; Hancock K; Millett J; de Wardener HE
    J Endocrinol; 1983 Aug; 98(2):221-6. PubMed ID: 6308123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic sodium loading and circulating inhibitor of Na+,K+-ATPase in rats].
    Delva P; Wauquier I; Devynck MA
    C R Acad Sci III; 1984; 299(20):867-70. PubMed ID: 6098351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of the natriuretic hormone to essential hypertension.
    de Wardener HE; MacGregor GA
    Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a circulating Na,K-pump inhibitor in essential hypertension.
    Hilton PJ
    Scand J Clin Lab Invest Suppl; 1986; 180():65-71. PubMed ID: 3012764
    [No Abstract]   [Full Text] [Related]  

  • 10. [Natriuretic hormone--current concepts].
    Januszewicz P; Wyszyńska T
    Pol Tyg Lek; 1984 Apr; 39(15):519-21. PubMed ID: 6091071
    [No Abstract]   [Full Text] [Related]  

  • 11. Endogenous digitalis-like factors revisited 1981-1985. A review.
    Schreiber V
    Cor Vasa; 1985; 27(1):92-100. PubMed ID: 2986905
    [No Abstract]   [Full Text] [Related]  

  • 12. Is a circulating sodium transport inhibitor involved in the pathogenesis of essential hypertension?
    MacGregor GA; de Wardener HE
    Clin Exp Hypertens (1978); 1981; 3(4):815-30. PubMed ID: 6271510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane transport of ions in hypertension: a review.
    Heagerty AM; Riozzi A; Brand SC; Bing RF; Thurston H; Swales JD
    Scand J Clin Lab Invest Suppl; 1986; 180():54-64. PubMed ID: 3012763
    [No Abstract]   [Full Text] [Related]  

  • 14. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased concentrations of a circulating sodium pump inhibitor in essential hypertension and uraemia and its partial purification from haemofiltrate.
    Wenzel M; Heidrich E; Kirch U; Moreth-Wolfrat K; Wizemann V; Schoner W
    Physiol Bohemoslov; 1990; 39(1):79-85. PubMed ID: 2165269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating inhibitors of sodium transport at the prehypertensive stage of essential hypertension.
    Haupert GT
    J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S70-6. PubMed ID: 2467109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
    de Wardener H
    Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of arterial hypertension].
    Distler A
    Rev Esp Cardiol; 1983; 36(6):461-2. PubMed ID: 6326209
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture.
    Morgan K; Foord SM; Spurlock G; Charalambous BM; Dieguez C; Scanlon MF; Mir MA
    Endocrinology; 1984 Oct; 115(4):1642-4. PubMed ID: 6148236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various aspects of sodium metabolism in hypertension].
    Debiński W; Wocial B
    Pol Tyg Lek; 1982 Nov; 37(44):1339-42. PubMed ID: 6298758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.